New Horizons Session
NH 2 - The arrival of immunotherapy: new horizons for radiologists
Lectures
1
Chairperson's introduction
05:00Ahmed Ba-Ssalamah, Vienna / AT
2
Immunotherapy: primers for radiologists
20:00Ahmed Ba-Ssalamah, Vienna / AT
3
Assessing immunotherapy response with functional imaging and radiomics
20:00Evis Sala, Rome / IT
4
Imaging appearances of immunotherapy adverse effects
20:00Sandra Baleato Gonzalez, SANTIAGO DE COMPOSTELA / ES
5
Panel discussion: How can imaging assess prognosis and response to immunotherapy?
25:00Ahmed Ba-Ssalamah, Vienna / AT, Evis Sala, Rome / IT, Sandra Baleato Gonzalez, SANTIAGO DE COMPOSTELA / ES
5 min
Chairperson's introduction
Ahmed Ba-Ssalamah, Vienna / Austria
20 min
Immunotherapy: primers for radiologists
Ahmed Ba-Ssalamah, Vienna / Austria
1. To have an overview of the mechanisms of action of immunotherapy on the immune system and on the cancer cells.
2. To learn about the different response patterns and their appearance on cross-section imaging modalities.
3. To understand the limitation of morphological assessment in response evaluation.
2. To learn about the different response patterns and their appearance on cross-section imaging modalities.
3. To understand the limitation of morphological assessment in response evaluation.
20 min
Assessing immunotherapy response with functional imaging and radiomics
Evis Sala, Rome / Italy
1. To discuss the role of functional imaging in assessing immunotherapy response.
2. To review the added value of radiomics in evaluation of response to immunotherapy.
3. To highlight the potential role of integrated multiomics in immunotherapy response assessment.
2. To review the added value of radiomics in evaluation of response to immunotherapy.
3. To highlight the potential role of integrated multiomics in immunotherapy response assessment.
20 min
Imaging appearances of immunotherapy adverse effects
Sandra Baleato Gonzalez, SANTIAGO DE COMPOSTELA / Spain
1. To review the pathophysiology of irAES.
2. To list the most common adverse effects, the incidence, and the median time to onset.
3. To recognise the imaging features of toxicities associated with IT based on different imaging techniques.
2. To list the most common adverse effects, the incidence, and the median time to onset.
3. To recognise the imaging features of toxicities associated with IT based on different imaging techniques.
25 min
Panel discussion: How can imaging assess prognosis and response to immunotherapy?
Ahmed Ba-Ssalamah, Vienna / Austria
Evis Sala, Rome / Italy
Sandra Baleato Gonzalez, SANTIAGO DE COMPOSTELA / Spain
Evis Sala, Rome / Italy
Sandra Baleato Gonzalez, SANTIAGO DE COMPOSTELA / Spain